title: Clonal cytogenetic abnormalities and BCL2 rearrangement in interdigitating dendritic cell sarcoma.
authors.forename: Hassan
authors.initials: H
authors.lastname: Nayer
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: Murphy
authors.forename: Anita L
authors.initials: AL
authors.lastname: Hawkins
authors.forename: Patricia P
authors.initials: PP
authors.lastname: Long
authors.forename: Maura
authors.initials: M
authors.lastname: Gillison
authors.forename: Michael
authors.initials: M
authors.lastname: Borowitz
authors.forename: Constance A
authors.initials: CA
authors.lastname: Griffin
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002869:Chromosome Aberrations; D003582:Cytogenetics / Q000379:methods; D003713:Dendritic Cells / Q000378:metabolism*; D017809:Fatal Outcome; D006801:Humans; D007150:Immunohistochemistry; D007621:Karyotyping; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics*; D012509:Sarcoma / Q000188:drug therapy* / Q000235:genetics*; D013365:Submandibular Gland Neoplasms / Q000188:drug therapy* / Q000235:genetics*
chemical_list: D000970:Antineoplastic Agents; D019253:Proto-Oncogene Proteins c-bcl-2